Abstract Objective To study the protective effect of breviscapine against brain injury induced by intrauterine inflammation in preterm rats and its mechanism. Methods A preterm rat model of brain injury caused by intrauterine inflammation was prepared by intraperitoneal injections of lipopolysaccharide in pregnant rats. The pregnant rats and preterm rats were respectively randomly divided into 5 groups: control, model, low-dose breviscapine (45 mg/kg), high-dose breviscapine (90 mg/kg), and high-dose breviscapine (90 mg/kg)+ML385 [a nuclear factor erythroid 2-related factor 2 (Nrf2) inhibitor, 30 mg/kg] (n=10 each). The number and body weight of the live offspring rats were measured for each group. Hematoxylin-eosin staining was used to observe the pathological morphology of the uterus and placenta of pregnant rats and the pathological morphology of the brain tissue of offspring rats. Immunofluorescent staining was used to measure the co-expression of ionized calcium binding adaptor molecule-1 (IBA-1) and nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) in the cerebral cortex of offspring rats. ELISA was used to measure the levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and interleukin-1β (IL-1β) in the brain tissue of offspring rats. Western blotting was used to measure the expression of Nrf2 pathway-related proteins in the brain tissue of offspring rats. Results Pathological injury was found in the uterus, and placenta tissue of the pregnant rats and the brain tissue of the offspring rats, and severe microglia pyroptosis occurred in the cerebral cortex of the offspring rats in the model group. Compared with the control group, the model group had significant reductions in the number and body weight of the live offspring rats and the protein expression levels of Nrf2 and heme oxygenase-1 (HO-1) in the brain tissue of the offspring rats (P<0.05), but significant increases in the relative fluorescence intensity of the co-expression of IBA-1 and NLRP3, the levels of the inflammatory factors IL-6, IL-8, and IL-1β, and the protein expression levels of NLRP3 and caspase-1 in the brain tissue of the offspring rats (P<0.05). Compared with the model group, the breviscapine administration groups showed alleviated pathological injury of the uterus and placenta tissue of the pregnant rats and the brain tissue of the offspring rats, significant increases in the number and body weight of the live offspring rats and the protein expression levels of Nrf2 and HO-1 in the brain tissue of the offspring rats (P<0.05), and significant reductions in the relative fluorescence intensity of the co-expression of IBA-1 and NLRP3, the levels of the inflammatory factors IL-6, IL-8, and IL-1β, and the protein expression levels of NLRP3 and caspase-1 in the brain tissue of the offspring rats (P<0.05). The high-dose breviscapine group had a significantly better effect than the low-dose breviscapine (P<0.05). ML385 significantly inhibited the intervention effect of high-dose breviscapine (P<0.05). Conclusions Breviscapine can inhibit inflammatory response in brain tissue of preterm rats caused by intrauterine inflammation by activating the Nrf2 pathway, and it can also inhibit microglial pyroptosis and alleviate brain injury.
WANG Si-Si,XIE Shuang-Shuang,MENG Yue-Xiu et al. Protective effect of breviscapine against brain injury induced by intrauterine inflammation in preterm rats and its mechanism[J]. CJCP, 2023, 25(2): 193-201.
WANG Si-Si,XIE Shuang-Shuang,MENG Yue-Xiu et al. Protective effect of breviscapine against brain injury induced by intrauterine inflammation in preterm rats and its mechanism[J]. CJCP, 2023, 25(2): 193-201.
von Chamier M, Reyes L, Hayward LF, et al. Nicotine induces maternal and fetal inflammatory responses which predispose intrauterine infection risk in a rat model[J]. Nicotine Tob Res, 2021, 23(10): 1763-1770. PMID: 33894055. PMCID: PMC8403242. DOI: 10.1093/ntr/ntab080.
Reiss JD, Peterson LS, Nesamoney SN, et al. Perinatal infection, inflammation, preterm birth, and brain injury: a review with proposals for future investigations[J]. Exp Neurol, 2022, 351: 113988. PMID: 35081400. DOI: 10.1016/j.expneurol.2022.113988.
Wu X, Wang B, Ma Q, et al. Mechanism of erythropoietin-induced M2 microglia polarization via Akt/Mtor/P70S6k signaling pathway in the treatment of brain injury in premature mice and its effect on biofilm[J]. Bioengineered, 2022, 13(5): 13021-13032. PMID: 35611764. PMCID: PMC9276024. DOI: 10.1080/21655979.2022.2073000.
Xie S, Jiang X, Doycheva DM, et al. Activation of GPR39 with TC-G 1008 attenuates neuroinflammation via SIRT1/PGC-1α/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats[J]. J Neuroinflammation, 2021, 18(1): 226. PMID: 34645465. PMCID: PMC8513331. DOI: 10.1186/s12974-021-02289-7.
Lee JY, Song H, Dash O, et al. Administration of melatonin for prevention of preterm birth and fetal brain injury associated with premature birth in a mouse model[J]. Am J Reprod Immunol, 2019, 82(3): e13151. PMID: 31131935. DOI: 10.1111/aji.13151.
Chang Y, Zhu J, Wang D, et al. NLRP3 inflammasome-mediated microglial pyroptosis is critically involved in the development of post-cardiac arrest brain injury[J]. J Neuroinflammation, 2020, 17(1): 219. PMID: 32703306. PMCID: PMC7376727. DOI: 10.1186/s12974-020-01879-1.
Costa T, Fernandez-Villalba E, Izura V, et al. Combined 1-deoxynojirimycin and ibuprofen treatment decreases microglial activation, phagocytosis and dopaminergic degeneration in MPTP-treated mice[J]. J Neuroimmune Pharmacol, 2021, 16(2): 390-402. PMID: 32564332. DOI: 10.1007/s11481-020-09925-8.
Ying YQ, Yan XQ, Jin SJ, et al. Inhibitory effect of LPS on the proliferation of oligodendrocyte precursor cells through the Notch signaling pathway in intrauterine infection-induced rats[J]. Curr Med Sci, 2018, 38(5): 840-846. PMID: 30341518. DOI: 10.1007/s11596-018-1951-9.
Suff N, Karda R, Diaz JA, et al. Ascending vaginal infection using bioluminescent bacteria evokes intrauterine inflammation, preterm birth, and neonatal brain injury in pregnant mice[J]. Am J Pathol, 2018, 188(10): 2164-2176. PMID: 30036519. PMCID: PMC6168615. DOI: 10.1016/j.ajpath.2018.06.016.
Amin N, Du X, Chen S, et al. Therapeutic impact of thymoquninone to alleviate ischemic brain injury via Nrf2/HO-1 pathway[J]. Expert Opin Ther Targets, 2021, 25(7):597-612. PMID: 34236288. DOI: 10.1080/14728222.2021.1952986.
